SEC Form 3 · accession 0000899243-19-000016

Zymeworks Inc. · ZYME

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Jan 1, 2019

Accepted (ET)

Jan 2, 2019 · 6:58 am EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001403752

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Shares	holding	—	—		—	137,223	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F6,F1	$4.75	holding	—	—	—	Aug 1, 2010	Jul 31, 2020	Common Shares	4,190	—	D
Stock Option (Right to Buy)^F6,F2	$14.44	holding	—	—	—	Jan 1, 2015	Jan 1, 2025	Common Shares	35,196	—	D
Stock Option (Right to Buy)^F6,F3	$22.60	holding	—	—	—	Mar 3, 2017	Feb 3, 2027	Common Shares	13,698	—	D
Stock Option (Right to Buy)^F6,F4	$22.60	holding	—	—	—	Apr 10, 2017	Feb 3, 2027	Common Shares	6,849	—	D
Stock Option (Right to Buy)^F4	$9.82	holding	—	—	—	Jun 12, 2018	Jun 12, 2027	Common Shares	6,285	—	D
Stock Option (Right to Buy)^F5	$17.20	holding	—	—	—	—	Jun 11, 2028	Common Shares	6,285	—	D

F1Stock options vest as follows: (i) 25% of underlying shares on first anniversary of grant date and (ii) remainder of underlying shares in 24 equal monthly installments on last day of month following first anniversary of grant date.
F2Stock options vest as follows: (i) 50% on grant date, (ii) 25% on first anniversary of grant date and (iii) 25% on second anniversary of grant date.
F3Stock options vest in 36 equal monthly installments starting one month after grant date.
F4Stock options vested on date of next annual general meeting following grant date.
F5Stock options vest on date of next annual general meeting following grant date of June 12, 2018.
F6Canadian dollars.

Exhibit List - Exhibit 24 - Power of Attorney